Skip to main content
. 2017 Mar 7;33(5):1011–1019. doi: 10.1007/s13187-017-1198-3

Table 2.

Differences in quality of life by sociodemographics and clinical characteristics (N = 436)

Emotional wellbeing Social functioning Pain General health
Characteristics Mean SD P Mean SD P Mean SD P Mean SD P
Gender Male 63.7 19.7 0.479 55.7 26.8 0.470 56.0 27.0 0.020 51.7 16.7 0.528
Female 62.3 20.4 57.7 27.7 49.7 26.8 50.5 18.3
Elderly No 62.1 20.9 0.374 58.9 27.2 0.065 51.4 27.7 0.557 52.2 18.0 0.054
Yes 63.9 18.9 53.9 27.4 52.9 25.9 48.9 17.1
University No 62.2 19.9 0.344 56.8 27.8 0.786 50.2 27.3 0.030 49.6 17.9 0.009
Yes 64.3 20.7 57.6 26.2 56.4 26.0 54.4 17.0
Employed No 62.8 19.6 0.978 57.7 26.6 0.389 51.5 26.1 0.584 49.9 17.5 0.054
Yes 62.9 21.7 55.1 29.3 53.2 29.6 53.7 18.2
Married No 62.5 19.9 0.848 60.0 26.7 0.218 53.9 25.8 0.421 52.3 17.4 0.379
Yes 62.9 20.3 56.1 27.5 51.4 27.4 50.5 17.9
Obese No 63.0 19.7 0.729 56.2 27.7 0.493 53.4 27.5 0.150 51.0 17.6 0.633
Yes 62.2 20.1 58.3 27.2 49.0 25.7 50.0 17.9
Family history of cancer No 64.4 19.9 0.011 58.7 28.0 0.028 54.3 28.0 0.002* 51.7 17.5 0.149
Yes 58.9 20.5 52.6 25.1 46.2 23.5 49.0 18.4
1st year after cancer diagnosis No 63.4 20.9 0.542 58.2 28.0 0.358 51.9 27.5 0.954 51.8 17.4 0.331
Yes 62.2 19.6 55.8 26.7 51.8 26.5 50.1 18.0
Cancer types Breast 61.4 20.0 0.161 58.4 28.2 0.278 49.0 26.6 0.073 50.7 19.2 0.564
Colorectal 65.7 20.3 54.6 24.0 52.7 26.2 50.0 14.8
Leukemia 60.9 21.8 56.6 27.4 56.8 25.0 49.1 20.6
Lymphoma 67.1 21.6 64.2 28.7 60.8 29.3 54.9 16.1
Others 60.5 18.5 54.5 28.8 49.6 27.5 51.2 18.2
Stage III/IV I/II 64.0 18.7 0.011 61.8 23.9 0.001* 55.4 25.5 0.001* 53.3 16.0 0.001*
III/IV 58.4 21.7 50.7 29.4 43.8 26.7 46.5 18.2
Multiple tumors No 64.5 19.7 0.003 59.4 26.3 0.004 55.6 26.5 0.001* 52.7 17.1 0.001*
Yes 58.3 20.7 51.2 28.8 42.6 25.9 46.5 18.4
Cancer surgery No 63.4 18.5 0.589 55.7 28.2 0.348 52.4 26.7 0.753 49.7 17.7 0.190
Yes 62.3 21.4 58.1 26.6 51.6 27.4 52.0 17.8
Chemotherapy No 63.9 21.1 0.527 59.2 26.9 0.365 58.2 28.8 0.008 51.6 18.6 0.678
Yes 62.5 19.9 56.3 27.5 50.1 26.2 50.7 17.5
Radiation therapy No 65.3 19.2 0.005 57.6 27.1 0.645 55.1 26.3 0.006 52.4 17.4 0.054
Yes 59.9 21.0 56.3 27.8 48.0 27.3 49.1 18.1
Immunotherapy No 64.5 19.3 0.073 57.4 26.4 0.771 56.9 25.8 0.001* 51.4 17.3 0.615
Yes 61.1 20.9 56.6 28.4 47.9 27.2 50.6 18.3
Antibodies No 63.4 20.4 0.333 57.5 27.5 0.332 53.0 26.1 0.431 51.1 17.5 0.993
Yes 61.3 19.0 54.5 27.5 50.4 29.6 51.0 19.2
Metastasis No 64.9 20.2 0.001* 59.9 26.5 0.001* 56.3 26.2 0.001* 53.6 17.0 0.001*
Yes 58.1 19.4 50.3 28.2 42.1 26.3 44.8 17.9
Fever No 66.4 18.5 0.001* 59.7 26.4 0.010 57.1 26.2 0.001* 54.1 17.8 0.001*
Yes 57.4 21.4 52.8 28.4 44.1 26.4 46.1 16.6
Family support No 59.5 24.8 0.292 57.4 28.2 0.919 54.5 30.3 0.547 48.8 17.0 0.440
Yes 63.1 19.7 57.0 27.3 51.7 26.7 51.1 17.8
Chronic disease other than cancer No 63.3 19.8 0.508 57.5 27.0 0.609 54.3 27.0 0.018 52.9 17.6 0.003
Yes 62.0 20.8 56.1 28.0 48.1 26.8 47.7 17.6
Regular exercise No 60.8 20.7 0.003 53.7 27.4 0.001* 48.2 26.7 0.001* 48.4 17.9 0.001*
Yes 66.9 18.4 63.8 26.0 59.7 26.1 56.2 16.3

*The variable is significant using Bonferroni correction cut-off at α/n = 0.05/24 = 0.0021, where n is the number of tests, P=P-value.